BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,151,908 | -21.5% | 1,456,629 | -1.2% | 0.24% | -18.7% |
| Q2 2023 | $93,187,768 | +91.4% | 1,474,490 | +36.2% | 0.30% | +75.9% |
| Q1 2023 | $48,699,381 | +8.5% | 1,082,449 | +5.6% | 0.17% | -1.2% |
| Q4 2022 | $44,888,339 | -36.6% | 1,024,614 | -4.6% | 0.17% | -38.6% |
| Q3 2022 | $70,785,000 | +31.6% | 1,074,284 | +0.9% | 0.28% | +40.7% |
| Q2 2022 | $53,800,000 | -22.4% | 1,065,128 | -1.9% | 0.20% | -3.9% |
| Q1 2022 | $69,343,000 | -63.0% | 1,085,516 | -37.9% | 0.21% | -59.1% |
| Q4 2021 | $187,198,000 | +6.0% | 1,747,721 | +1.8% | 0.51% | +1.6% |
| Q3 2021 | $176,542,000 | +93.7% | 1,717,164 | +65.8% | 0.50% | +74.1% |
| Q2 2021 | $91,119,000 | -11.5% | 1,035,918 | -2.2% | 0.29% | -14.4% |
| Q1 2021 | $102,993,000 | -6.6% | 1,059,271 | +7.8% | 0.33% | -9.0% |
| Q4 2020 | $110,223,000 | – | 982,814 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |